BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191116
DTSTAMP:20260515T032619
CREATED:20190213T093434Z
LAST-MODIFIED:20190214T153532Z
UID:19515-1573516800-1573862399@www.pharmajournalist.com
SUMMARY:TIDES Europe: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES Europe is Europe’s #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate new products to market. \n \n400+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n40+ CASE STUDIES AND NEW DATA PRESENTATIONS\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \n30+ LEADING EXHIBITORS\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \nRegister now at www.TIDESEuropeEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-europe-oligonucleotide-peptide-therapeutics/
LOCATION:RAI Amsterdam | Amsterdam\, Netherlands
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032619
CREATED:20190812T093209Z
LAST-MODIFIED:20190812T093329Z
UID:21936-1573516800-1573775999@www.pharmajournalist.com
SUMMARY:Data Analytics for Pharma Development 2019
DESCRIPTION:Following a hugely successful event in Amsterdam last year\, we’re excited to inform you that the 5th Annual Data Analytics for Pharma Development Forum will be taking place in Munich from the 13-14 November 2019. Read all about it here:  Download the 2019 Agenda. \n \nThe industry needs to move past the challenge of unstructured data sets and integrating data from multiple sources to begin to work collaboratively with other departments and organisations\, as well as create a real world evidence framework for our pharmaceutical development through effective data utilisation. This is why we’ve curated an industry leading program with inside expertise from the top. \nSo – who exactly will be there? \nScientific Director\, Janssen\nPrinciple Data Scientist\, Novo Nordisk\nPrincipal Scientist Digitalisation Lead in Large Molecule Research\, Roche\nSenior Director\, Head\, Global Real World Evidence Strategy and Analytics\, Biogen\nHealth Informatics Director\, AstraZeneca\nVice President AI and Machine Learning\, BERG Health\nDirector\, Data Science IKU in EMEA\, Celgene\nGlobal HEOR Evidence Expert Lead\, Sanofi\nHead Quantitative Sciences\, Bill & Melinda Gates Medical Research Institute \nFor the first time ever we also bring you the Start-Up Afternoon\, where 5+ innovative data-management start ups demonstrate their technology in lightning-round presentations. \nWe also know that people learn better when they’re being active\, so this year we also running Certificate Course in Data Analytics to deep-dive into data strategy\, advanced analytics and machine learning & AI to ensure you’re at the forefront of innovation. \nWe encourage the sharing of challenges and success stories through an interactive program – but most importantly\, we facilitate open discussions during networking opportunities where our delegates from Big Pharma\, biotech\, and start-ups will be looking to you to inform their next step on how to optimise their data strategy. \nWith 50+ attendees and an expert speaker faculty of over 20 senior decision makers\, the Data Analytics forum is Europe’s industry leading event. \nDownload the 2019 Agenda here to find out more about the forum
URL:https://www.pharmajournalist.com/event/data-analytics-for-pharma-development-2019/
LOCATION:Hilton Munich City\, Rosenheimer Str. 15\, München\, 81667\, Germany
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191114
DTSTAMP:20260515T032619
CREATED:20190916T083615Z
LAST-MODIFIED:20190916T083615Z
UID:22433-1573516800-1573689599@www.pharmajournalist.com
SUMMARY:Protein Engineering Congress EU
DESCRIPTION:Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate\, with competition within industries high and the need to optimise performance greater than ever. \nIntroducing the European Protein Engineering Congress\, dedicated to uncovering the new and emerging practices\, techniques and methods of protein and enzyme engineering across industries. \nWith pharmaceutical\, flavour & fragrance\, consumer goods\, animal feed\, and agrochemical sectors all approaching the design\, build and generation of new biocatalysts and molecules not found in nature\, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
URL:https://www.pharmajournalist.com/event/protein-engineering-congress-eu/
LOCATION:Radisson Blu Hotel Frankfurt\, Franklinstrasse 65\, 60486\, Frankfurt am Main\, Germany
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191113
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032619
CREATED:20190731T104534Z
LAST-MODIFIED:20190731T113531Z
UID:21753-1573603200-1573775999@www.pharmajournalist.com
SUMMARY:5th annual European Microbiome Congress
DESCRIPTION:The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune\, nervous and metabolic systems couple the microbiome with the rest of the body and thus play a crucial and interlinking role in extra-intestinal diseases including neurological\, cancer and metabolic conditions. \n \nFor the 5th annual European Microbiome Congress\, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society. \nJoin key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find out how others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat cancer\, metabolic\, neurodegenerative and psychiatric disorders. \nTo learn more about 5th annual European Microbiome Congress\, and to register online\, visit https://microbiomecongress.com
URL:https://www.pharmajournalist.com/event/5th-annual-european-microbiome-congress/
LOCATION:Olympia Conference Centre\, Hammersmith Rd\, Hammersmith\, London W14 8UX
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191113
DTEND;VALUE=DATE:20191115
DTSTAMP:20260515T032619
CREATED:20190829T084945Z
LAST-MODIFIED:20190829T085516Z
UID:22152-1573603200-1573775999@www.pharmajournalist.com
SUMMARY:Skin Microbiome Congress EU
DESCRIPTION:With 2.35 billion Euros being spent on cosmetic product R&D in Europe\, and Skin Microbiome being “2019’s hottest skin care trend” – a claim supported by major market researchers and beauty bibles\, are you ready for the next generation of skin care? \nWe are bringing you the first data focused Skin Microbiome event with two concurrent tracks focused on the hard data and commercial sides of skin microbiome: \n\nData Track: focuses on the hard data that supports and legitimises product claims and drives increased understanding of the skin microbiome.\nCommercial Track: tackles the challenges faced when building a commercially viable skin microbiome company\, optimising your supply chain and executing successful marketing & communication strategies.\n\nDiscover the potential of prebiotic\, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: \n\nEffective Networking with 150+ innovators\, start-ups\, multinational companies and vendors.\nCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria\, bacterial extracts\, or active ingredients to promote & protect the skins microbiome.\nConsumer Trends – Understand how consumer trends towards natural\, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome.\nClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics.\nCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity\, gaining market share with scientifically backed products.\nRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product.\n\nWith an increasing consumer trend towards natural products\, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products!
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress-eu/
LOCATION:Olympia London\, Hammersmith Road\, Kensington\, London\, W14 8UX
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR